Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults
Spyros A. Kalams(Vanderbilt University Medical Center), Marnie Elizaga(Fred Hutch Cancer Center), Magda Sobieszczyk(Columbia University), David B. Weiner(The Wistar Institute), Xia Jin(Anhui Medical University), John H. Eldridge(Profectus Biosciences (United States)), M. Cardinali(National Institute of Allergy and Infectious Diseases), Barbara Metch(Fred Hutch Cancer Center), Scott Parker(University of Alabama), Artur Olhovetchi Kalichman, Lindsey R. Baden(Brigham and Women's Hospital), Maggie Haitian Wang(Chinese University of Hong Kong), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michael D. Lubeck(Pfizer (United States)), Vinai Suriyanon(Maharaj Nakorn Chiang Mai Hospital), William A. Blattner(Unknown)
Cited by 111
Related Papers
Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
|The Journal of Experimental Medicine|1999|1.4k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981